A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer

Ian Ganly, David Kirn, Susan G. Eckhardt, Gail I. Rodriguez, David S. Soutar, Randol Otto, Andrew G. Robertson, Oirhigh Park, Mark L. Gulley, Carla Heise, Daniel D. Von Hoff, Stanley B. Kaye

Research output: Contribution to journalArticlepeer-review

390 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences